Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

Norge Nyheter Nyheter

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Norge Siste Nytt,Norge Overskrifter
  • 📰 ScienceMagazine
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 63%

Structures of the SARSCoV2 Omicron variant bound to a therapeutic antibody and to the human ACE2 receptor reveal how Omicron retains high affinity binding to ACE2 while inhibiting binding to many antibodies that neutralize earlier variants.

). These efforts offer hope that the same strategies that contribute to solving the current pandemic will prepare us for possible future sarbecovirus pandemics.

. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

ScienceMagazine /  🏆 285. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesCannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responsesPreclinical experiments in human cells and mice suggest CBD may prevent the replication of SARSCoV2, but the authors advise caution until completion of a clinical trial, citing questions on dosage, formulation, and mode of delivery. ScienceAdvances
Les mer »

How does Omicron spread so fast? A high viral load isn’t the answerData on viral levels point to immune evasion as a cause of the variant’s transmissibility.
Les mer »

How does Omicron spread so fast? A high viral load isn’t the answerData on viral levels point to immune evasion as a cause of the variant’s transmissibility.
Les mer »

Why scientists are racing to develop more COVID antiviralsThe first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Les mer »

Why scientists are racing to develop more COVID antiviralsThe first crop of antivirals against SARS-CoV-2 is promising. But new drugs will be needed to counter the looming threat of resistance.
Les mer »

Even Mild Covid-19 Can Cause Brain Dysfunction And Cognitive IssuesEven Mild Covid-19 Can Cause Brain Dysfunction And Cognitive IssuesThe research provides new clues as to why some people with long Covid experience long-term cognitive issues after being infected with the SARS-CoV-2 coronavirus.
Les mer »



Render Time: 2025-04-22 05:07:24